Familial hypocalciuric hypercalcaemia type 3: AP2S1 missense mutation

BMJ Case Rep. 2020 Nov 9;13(11):e236631. doi: 10.1136/bcr-2020-236631.

Abstract

A 45-year-old man was referred to endocrine for the evaluation of hypercalcaemia. The calcium was elevated, vitamin D was low with a normal parathyroid hormone. Dual-energy X-ray absorptiometry scan revealed osteoporosis at the lumbar spine and femoral neck. A 24-hour urine collection revealed low urinary calcium, which was believed to be secondary to vitamin D deficiency. A diagnosis of primary hyperparathyroidism was made. The patient underwent a four-gland parathyroid exploration surgery in which three of his parathyroid glands were removed. The pathology was consistent with benign parathyroid tissue. Post surgery, the patient had persistently elevated calcium levels. He was then started on bisphosphonate and cinacalcet for osteoporosis and hypercalcaemia, respectively. Genetic analysis of familial hypocalciuric hypercalcaemia (FHH) showed a p.arg15cys mutation in the AP2S1 gene, confirming the diagnosis of FHH type 3.

Keywords: calcium and bone; endocrine system.

Publication types

  • Case Reports

MeSH terms

  • Adaptor Protein Complex 2 / genetics*
  • Adaptor Protein Complex 2 / metabolism
  • Adaptor Protein Complex sigma Subunits / genetics*
  • Adaptor Protein Complex sigma Subunits / metabolism
  • DNA / genetics*
  • DNA Mutational Analysis
  • Diagnosis, Differential
  • Humans
  • Hypercalcemia / congenital*
  • Hypercalcemia / diagnosis
  • Hypercalcemia / genetics
  • Hypercalcemia / metabolism
  • Male
  • Middle Aged
  • Mutation, Missense*
  • Tomography, X-Ray Computed
  • Ultrasonography

Substances

  • AP2S1 protein, human
  • Adaptor Protein Complex 2
  • Adaptor Protein Complex sigma Subunits
  • DNA

Supplementary concepts

  • Hypocalciuric hypercalcemia, familial, type 1